Druggable Vulnerabilities in Therapy-Resistant Lung Cancers
Publication
, Conference
Wood, KC
Published in: JOURNAL OF THORACIC ONCOLOGY
February 1, 2020
Duke Scholars
Published In
JOURNAL OF THORACIC ONCOLOGY
EISSN
1556-1380
ISSN
1556-0864
Publication Date
February 1, 2020
Volume
15
Issue
2
Start / End Page
S6 / S6
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wood, K. C. (2020). Druggable Vulnerabilities in Therapy-Resistant Lung Cancers. In JOURNAL OF THORACIC ONCOLOGY (Vol. 15, pp. S6–S6). ELSEVIER SCIENCE INC.
Wood, K. C. “Druggable Vulnerabilities in Therapy-Resistant Lung Cancers.” In JOURNAL OF THORACIC ONCOLOGY, 15:S6–S6. ELSEVIER SCIENCE INC, 2020.
Wood KC. Druggable Vulnerabilities in Therapy-Resistant Lung Cancers. In: JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC; 2020. p. S6–S6.
Wood, K. C. “Druggable Vulnerabilities in Therapy-Resistant Lung Cancers.” JOURNAL OF THORACIC ONCOLOGY, vol. 15, no. 2, ELSEVIER SCIENCE INC, 2020, pp. S6–S6.
Wood KC. Druggable Vulnerabilities in Therapy-Resistant Lung Cancers. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC; 2020. p. S6–S6.
Published In
JOURNAL OF THORACIC ONCOLOGY
EISSN
1556-1380
ISSN
1556-0864
Publication Date
February 1, 2020
Volume
15
Issue
2
Start / End Page
S6 / S6
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology